Shetty, Neil http://orcid.org/0000-0003-1158-5916
Article History
Accepted: 18 January 2022
First Online: 2 March 2022
Declarations
:
: Neil Shetty serves as a site principal investigator for the Jazz Pharmaceuticals CX-8998 phase 2b clinical trial in essential tremor.
: This article does not contain any studies with human or animal subjects performed by any of the authors.